MENU
IMUC
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
EOM Pharmaceutical Holdings (IMUC) Ownership - Who owns EOM Pharmaceutical Holdings?
EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve the lives of patients suffering from debilitating and sometimes deadly diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
136 Summit Avenue
Phone
+1 201 351-0605
Employees
4
Web
https://www.eompharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.49M
P/E Ratio
0.02
Total Cash
85.29K
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMUC
Capitalization
8.49M
P/E Ratio
0.02
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
85.3K
Total Cash/Share
0.00
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
3.43M
P/B Ratio
0.35
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4.19K
Current Ratio
9.53
Current Revenue Per Employee
150000.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
127M
Total Liabilities
2.36M
Total Volume MTD
N/A
Value
1
Gain YTD
-60.249
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of immune based therapies for the treatment of brain and other cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
136 Summit Avenue
Phone
+1 201 351-0605
Employees
4
Web
https://www.eompharma.com